南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

ISGylation修饰稳定STING蛋白阻止自噬降解并促进肺癌抗肿瘤免疫机制

ISGylation prevents autophagic degradation of STING and promotes antitumor immunity in lung cancer

Cao Dan, Huang Bin, Fu Xinming, Liu Ming, Niu Xiaogang, Zhai Hongbin, Huang Hao

Journal:Cell Death & Disease

IF:9.6

DOI:10.1038/s41419-026-08527-1

PMID:

Published:2026-02-27

research field:分子生物学细胞信号传导癌症免疫学翻译后修饰免疫治疗

Abstract

The STING pathway plays a central role in immune activation; however, STING protein levels decline during the progression of various cancers, including lung cancer, thereby limiting the efficacy of immunotherapies. Our study uncovers a previously unrecognized mechanism whereby ISGylation stabilizes STING by preventing its autophagic degradation, thereby enhancing its immunostimulatory function. Moreover, we demonstrate USP18 as a negative regulator that removes ISGylation from STING, and identify Tanshinone IIA sulfonate (TST) as a potent USP18 inhibitor that enhances STING ISGylation and stabilizes STING protein levels. When combined with the STING agonist diABZi, TST exhibits a synergistic effect, eliciting a potent antitumor immune response by increased infiltration of NK1.1⁺ cells and pronounced suppression of tumor growth in lung cancer models. These findings underscore the therapeutic potential of targeting STING ISGylation, particularly in patients with low STING expression who often respond poorly to current STING-targeted therapies.

本文使用的Yeasen产品

购物车
客服
转染试用